Isabell Remus serves as the Global Head of Biosimilars at Sandoz, where she is responsible for expanding market leadership, supporting pipeline growth, and enhancing access to essential biosimilar medicines. She joined Sandoz over 15 years ago and has dedicated her career to pioneering access to affordable, high-quality medicines, particularly biosimilars, which are crucial for patient access and sustainable healthcare systems.